Article Details
Retrieved on: 2021-02-02 09:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The size of the transaction was driven, in part, by Alexion's pipeline of rare blood disease treatments and its blockbuster drug Soliris. Such medicines ...
Article found on: www.raconteur.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here